CareDx CDNA shares ended the last trading session 11.2% higher at $24.91. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session.

CareDx CDNA shares rallied 6.1% in the last trading session to close at $25.07. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session.

CareDx, Inc (NASDAQ:CDNA – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the seven research firms that are currently covering the stock, MarketBeat.com reports. Three ...

BRISBANE, Calif., March 11, 2025--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of ...

In a report released yesterday, Mark Massaro from BTIG reiterated a Buy rating on CareDx (CDNA – Research Report), with a price target of ...

Ark Invest's Cathie Wood-led funds made significant trades involving GitLab, Intellia, Prime Medicine, UiPath, Ibotta, Roblox ...

Good afternoon, everyone. Welcome to the CareDx, Inc. Fourth Quarter and Fiscal Year 2024 Earnings Conference Call. At this time, all participants are in a listen-only-mode. Later, you will have ...

CareDx (CDNA) reported $86.58 million in revenue for the quarter ended December 2024, representing a year-over-year increase of 32%. EPS of $0.18 for the same period compares to -$0.17 a year ago.

The new MessageBOOSTER cDNA Synthesis from Cell Lysates kit eliminates these difficulties by enabling RNA amplification and cDNA synthesis directly from cell lysates, without the need to purify ...

Through laboratory techniques that track quantities of mRNA, scientists can identify which genes are “turned on” and which are “turned off” in an organism’s tissue at a given time, as ...